O'Shares Investment Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-63,614
Closed -$15.4M 12
2022
Q1
$15.4M Buy
63,614
+3,553
+6% +$816K 1.22% 18
2021
Q4
$13.5M Buy
60,061
+4,364
+8% +$921K 0.97% 22
2021
Q3
$11.8M Sell
55,697
-8,835
-14% -$2.03M 0.87% 22
2021
Q2
$15.7M Buy
64,532
+1,669
+3% +$411K 1.11% 19
2021
Q1
$15.6M Sell
62,863
-72
-0.1% -$17.2K 1.16% 17
2020
Q4
$14.5M Buy
62,935
+5,807
+10% +$1.34M 1.1% 18
2020
Q3
$14.5M Buy
57,128
+13,759
+32% +$3.41M 1.51% 14
2020
Q2
$10.2M Buy
43,369
+3,901
+10% +$890K 1.28% 16
2020
Q1
$8M Sell
39,468
-30
-0.1% -$6.55K 1.43% 17
2019
Q4
$9.52M Buy
39,498
+2,608
+7% +$575K 1.31% 17
2019
Q3
$7.14M Buy
36,890
+8,842
+32% +$1.7M 1.08% 23
2019
Q2
$5.17M Buy
28,048
+1,632
+6% +$292K 0.83% 29
2019
Q1
$5.02M Buy
26,416
+614
+2% +$117K 0.85% 28
2018
Q4
$5.02M Buy
+25,802
New +$5.03M 0.96% 26

Other funds holding AMGN

O'Shares Investment Advisers's AMGN Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Amgen (AMGN) in Q2 2022, closing a stake of 63,614 shares — an estimated $15.4M sold.

O'Shares Investment Advisers first reported a position in AMGN in Q4 2018 and held it in 14 quarters. The position peaked at $15.7M in Q2 2021. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 63,614 Amgen shares in Q2 2022, an estimated $15.4M.
  • O'Shares Investment Advisers first reported a position in Amgen in Q4 2018 and held it in 14 quarters.
  • O'Shares Investment Advisers's Amgen position peaked at $15.7M in Q2 2021.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.